CDKN1C antibody (AA 291-343) (PE)
Quick Overview for CDKN1C antibody (AA 291-343) (PE) (ABIN6988146)
Target
See all CDKN1C AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 291-343
-
Cross-Reactivity
- Human, Mouse, Rat
-
Predicted Reactivity
- Cow,Sheep
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from rat Cdkn1c
-
Isotype
- IgG
-
-
-
-
Application Notes
- FCM 1:20-100
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- CDKN1C (Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C))
-
Alternative Name
- CDKN1C
-
Background
-
Synonyms: p57, Kip2, p57KIP2
Background: This gene is imprinted, with preferential expression of the maternal allele. The encoded protein is a tight-binding, strong inhibitor of several G1 cyclin/Cdk complexes and a negative regulator of cell proliferation. Mutations in this gene are implicated in sporadic cancers and Beckwith-Wiedemann syndorome, suggesting that this gene is a tumor suppressor candidate. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Oct 2010].
-
Gene ID
- 246060
-
Pathways
- Cell Division Cycle, Dopaminergic Neurogenesis
Target
-